Annovis Bio Inc

Company Profile

Annovis Bio Inc had its IPO on 2010-02-12 under the ticker symbol ANVS.

The company operates in the Healthcare sector and Biotechnology industry. Annovis Bio Inc has a staff strength of 3 employees.

Stock update

Shares of Annovis Bio Inc opened at $11.49 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $11.05 - $11.49, and closed at $11.15.

This is a -3.46% slip from the previous day's closing price.

A total volume of 12,280 shares were traded at the close of the day’s session.

In the last one week, shares of Annovis Bio Inc have slipped by -9.64%.

Annovis Bio Inc's Key Ratios

Annovis Bio Inc has a market cap of $132.75 million, indicating a price to book ratio of 3.2862 and a price to sales ratio of 0.

In the last 12-months Annovis Bio Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Annovis Bio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Annovis Bio Inc’s operating margin was 0% while its return on assets stood at -44.08% with a return of equity of -73.6%.

In Q3, Annovis Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Annovis Bio Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-3.28 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Annovis Bio Inc’s profitability.

Annovis Bio Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -2.3519. Its price to sales ratio in the trailing 12-months stood at 0.

Annovis Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$32.49 million

Total Liabilities

$2.53 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Annovis Bio Inc ended 2025 with $32.49 million in total assets and $0 in total liabilities. Its intangible assets were valued at $32.49 million while shareholder equity stood at $29.96 million.

Annovis Bio Inc ended 2025 with $0 in deferred long-term liabilities, $2.53 million in other current liabilities, 816.00 in common stock, $-50959997.00 in retained earnings and $0 in goodwill. Its cash balance stood at $31.99 million and cash and short-term investments were $31.99 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Annovis Bio Inc’s total current assets stands at $32.49 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.85 million and inventory worth $0.

In 2025, Annovis Bio Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Annovis Bio Inc paid $0 in dividends in 2025.

Other key metrics

Current Trading Price

$11.15

52-Week High

$23.91

52-Week Low

$8.39

Analyst Target Price

$46

Annovis Bio Inc stock is currently trading at $11.15 per share. It touched a 52-week high of $23.91 and a 52-week low of $23.91. Analysts tracking the stock have a 12-month average target price of $46.

Its 50-day moving average was $12.95 and 200-day moving average was $14.22 The short ratio stood at 2.75 indicating a short percent outstanding of 0%.

Around 3094% of the company’s stock are held by insiders while 913.6% are held by institutions.